Medicare Enrolled
Dr. Ranjana Mehta, MD
Pulmonary Disease · East Moriches, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mehta from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mehta?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mehta
Dr. Ranjana Mehta is a pulmonary disease specialist in East Moriches, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Mehta performed 1,991 Medicare services across 1,239 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mehta received a total of $4,740 from 37 pharmaceutical and/or device companies across 219 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mehta is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 21% volume in NY
$4,740 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,991
Medicare services
Top 21% in NY for pulmonary disease
1,239
Unique beneficiaries
$87
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~105 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
916 | $108 | $360 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
152 | $73 | $245 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
125 | $36 | $70 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
122 | $8 | $18 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
116 | $72 | $90 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
100 | $151 | $350 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
81 | $168 | $487 |
| COVID-19 amplified DNA/RNA probe detection A laboratory test that uses amplified DNA or RNA probes to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) antigen. |
69 | $50 | $130 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
65 | $13 | $90 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
45 | $12 | $100 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
42 | $3 | $15 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
40 | $3 | $18 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
22 | $153 | $445 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
22 | $41 | $150 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
21 | $262 | $718 |
| Pneumococcal vaccine, 23-valent A vaccine that protects against 23 types of pneumococcal bacteria. It is used to prevent infections caused by these bacteria. |
19 | $124 | $170 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
18 | $36 | $70 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
16 | $182 | $535 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$4,740
Total received (2018-2024)
Avg $677/year across 7 years
Top 29% in NY for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
219
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,740 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,320
2023
$775
2022
$960
2021
$294
2020
$329
2019
$557
2018
$506
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$330
Bayer Healthcare Pharmaceuticals Inc.
$279
Amneal Pharmaceuticals LLC
$130
PFIZER INC.
$98
Lilly USA, LLC
$85
Phathom Pharmaceuticals, Inc.
$77
Novo Nordisk Inc
$73
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$56
Exact Sciences Corporation
$45
Daiichi Sankyo Inc.
$38
Amgen Inc.
$22
Ardelyx, Inc.
$22
Abbott Laboratories
$21
Boehringer Ingelheim Pharmaceuticals, Inc.
$15
GlaxoSmithKline, LLC.
$15
Avvisto Therapeutics, LLC
$14
Top 3 companies account for 56.0% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$788
Boehringer Ingelheim Pharmaceuticals, Inc.
$575
Novo Nordisk Inc
$385
Lilly USA, LLC
$358
Bayer Healthcare Pharmaceuticals Inc.
$279
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$273
PFIZER INC.
$260
Regeneron Healthcare Solutions, Inc.
$242
GlaxoSmithKline, LLC.
$147
Daiichi Sankyo Inc.
$140
Merck Sharp & Dohme Corporation
$139
Amneal Pharmaceuticals LLC
$130
Janssen Pharmaceuticals, Inc
$121
Phathom Pharmaceuticals, Inc.
$77
Amarin Pharma Inc.
$70
Endo Pharmaceuticals Inc.
$68
Exact Sciences Corporation
$68
Allergan Inc.
$67
Merck Sharp & Dohme LLC
$65
Inspire Medical Systems, Inc.
$55
Baxter Healthcare
$50
E.R. Squibb & Sons, L.L.C.
$45
Amgen Inc.
$40
Sunovion Pharmaceuticals Inc.
$39
Abbott Laboratories
$39
ARBOR PHARMACEUTICALS, INC.
$32
Dynavax Technologies Corporation
$25
EISAI INC.
$24
Ardelyx, Inc.
$22
Circassia Pharmaceuticals Inc
$21
Alexion Pharmaceuticals, Inc.
$19
Shield Therapeutics Inc
$14
Kowa Pharmaceuticals America, Inc.
$14
Avvisto Therapeutics, LLC
$14
SANOFI PASTEUR INC.
$13
Philips Electronics North America Corporation
$12
Ultragenyx Pharmaceutical Inc.
$12
Top 3 companies account for 36.9% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AIRSUPRA · Aduhelm · BREZTRI · BYDUREON · BYSTOLIC · CYCLOSET · Cologuard Collection Kit · DUPIXENT · ELIQUIS · EMGALITY · EVENITY · Edarbi · FARXIGA · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FREESTYLE LIBRE 3 · FreeStyle Libre blood glucose Flash Monitoring System · Heplisav-B · Hillrom - Connex Spot Monitor · IBSRELA · INJECTAFER · INSPIRE · JANUVIA · JARDIANCE · Kerendia · LONHALA MAGNAIR · Livalo · MOUNJARO · NASCOBAL · NUCALA · NURTEC ODT · OFEV · Ozempic · PNEUMOVAX 23 · PREVNAR 20 · SHINGRIX · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO · STIOLTO RESPIMAT · SYNJARDY · Saxenda · Strensiq · TEZSPIRE · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · TUDORZA PRESSAIR · Trilogy 100 · UNITHROID · Utibron · VIBERZI · VOQUEZNA · VYNDAMAX · Vascepa · Wegovy · XARELTO · XIFAXAN · ZEPBOUND
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pulmonary diseases within 10 mi
40
Per 100K population
2.6
County median income
$128,329
Nearest hospital
PECONIC BAY MEDICAL CENTER
10.0 mi
10.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mehta is a clinical cardiology specialist, with above-average Medicare volume (top 21% in NY), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mehta experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Mehta performed 916 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mehta receive payments from pharmaceutical companies?
Yes. Dr. Mehta received a total of $4,740 from 37 companies across 219 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mehta's costs compare to other pulmonary diseases in East Moriches?
Dr. Mehta's average Medicare payment per service is $87. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mehta) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in East Moriches
Browse pulmonary diseases in East Moriches ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in NY
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in NY
Which NY pulmonary diseases receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology